Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.

Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.

Abstract: An expansion of the display of graphical content over multiple spatially separated smart monitors of an in-flight entertainment system involves initiating data communications links between each of the multiple smart monitors. A background graphical content is segmented into corresponding sections for each of the multiple smart monitors, with being unique to a specific one. Each of the sections of the background graphical content are displayed on the respective smart monitors, and a moving foreground graphical content is animated across one or more of the smart monitors. Transitions of the moving foreground graphical content from an originating one of the smart monitors to a destination one of the smart monitors is communicated over the corresponding data communications link initiated therewith. Inputs from the smart monitors are received to correspondingly modify the animating of the moving foreground graphical content.

Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.

Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.

Abstract: The present invention provides isolated IL-33 proteins, active fragments thereof and antibodies, antigen binding fragments thereof, against IL-33 proteins. Also provided are methods of modulating cytokine activity, e.g., for the purpose of treating immune and inflammatory disorders.

Abstract: An interior component for a vehicle may include a nonwoven fabric impregnated with a resin. The nonwoven fabric and resin are consolidated into a solid sheet devoid of pockets. The interior component may exclude metal coated filler particles and lubricants. The method of making the interior component includes the steps of: forming a nonwoven fabric of a staple fiber and a resin, consolidating the nonwoven fabric and the resin into a solid sheet, and forming the solid sheet into the vehicle component. The vehicle may be an airplane, train, subway car, light rail car, bus, or automobile. The resin may be a polymer selected from the group consisting of polyphenylene sulfide, polyetherimide, polyaryletherketone, co-polymers thereof, and combinations thereof.

Abstract: An interior component for a vehicle may include a nonwoven fabric impregnated with a resin. The nonwoven fabric and resin are consolidated into a solid sheet devoid of pockets. The interior component may exclude metal coated filler particles and lubricants. The method of making the interior component includes the steps of: forming a nonwoven fabric of a staple fiber and a resin, consolidating the nonwoven fabric and the resin into a solid sheet, and forming the solid sheet into the vehicle component. The vehicle may be an airplane, train, subway car, light rail car, bus, or automobile. The resin may be a polymer selected from the group consisting of polyphenylene sulfide, polyetherimide, polyaryletherketone, co-polymers thereof, and combinations thereof.

Abstract: The present invention provides data to demonstrate that the re-fusion, of a mammalian karyoplast to an enucleated in vivo ovulated oocyte, following an unsuccessful initial simultaneous electrical fusion and activation event offers an additional alternative and improvement in the creation of activated and fused nuclear transfer-capable embryos for the production of live offspring in various mammalian non-human species including goats, pigs, rodents, primates, rabbits and cattle. Additionally, multiple electrical pulses offers an alternative and more efficient activation method in a simultaneous fusion and activation methodology for viable offspring production in a animal nuclear transfer program.

Abstract: The present invention provides data to demonstrate that the fusion performance of a cell-line in procedures involving fusion and cleavage indices either alone or in combination are a means for selecting a cell lines that will be successful in a nuclear transfer or microinjection program. This technique and method of selecting a cell line offers an additional alternative and improvement in the creation of activated and fused nuclear transfer-capable embryos for the production of live offspring in various mammalian non-human species including goats, pigs, rodents, primates, rabbits and cattle.

Abstract: The present invention provides data to demonstrate that the re-fusion, of a mammalian karyoplast to an enucleated in vivo ovulated cocyte, following an unsuccessful initial simultaneous electrical fusion and activation event offers an additional alternative and improvement in the creation of activated and fused nuclear transfer-capable embryos for the production of live off-spring in various mammalian non-human species including goats, pigs, rodents, primates, rabbits and cattle. Additionally, multiple electrical pulses offers an alternative and more efficient activation method in a simultaneous fusion and activation methodology for viable offspring production in a animal nuclear transfer program.